Iron status in patients with pyruvate kinase deficiency: neonatal hyperferritinaemia associated with a novel frameshift deletion in the PKLR gene (p.Arg518fs), and low hepcidin to ferritin ratios

Pyruvate kinase (PK) deficiency is an iron‐loading anaemia characterized by chronic haemolysis, ineffective erythropoiesis and a requirement for blood transfusion in most cases. We studied 11 patients from 10 unrelated families and found nine different disease‐causing PKLR mutations. Two of these mutations ‐ the point mutation c.878A>T (p.Asp293Val) and the frameshift deletion c.1553delG (p.(Arg518Leufs*12)) ‐ have not been previously described in the literature. This frameshift deletion was associated with an unusually severe phenotype involving neonatal hyperferritinaemia that is not typical of PK deficiency. No disease‐causing mutations in genes associated with haemochromatosis could be found. Inappropriately low levels of hepcidin with respect to iron loading were detected in all PK‐deficient patients with increased ferritin, confirming the predominant effect of accelerated erythropoiesis on hepcidin production. Although the levels of a putative hepcidin suppressor, growth differentiation factor‐15, were increased in PK‐deficient patients, no negative correlation with hepcidin was found. This result indicates the existence of another as‐yet unidentified erythroid regulator of hepcidin synthesis in PK deficiency.

[1]  Tatiana Ammosova,et al.  Chuvash polycythemia VHLR200W mutation is associated with down-regulation of hepcidin expression. , 2011, Blood.

[2]  Tomas Ganz,et al.  Hepcidin and iron regulation, 10 years later. , 2011, Blood.

[3]  C. Camaschella,et al.  Inherited disorders of iron metabolism , 2011, Current opinion in pediatrics.

[4]  A. Pietrangelo Hereditary hemochromatosis: pathogenesis, diagnosis, and treatment. , 2010, Gastroenterology.

[5]  Jeffery L. Miller,et al.  Iron Loading and Overloading due to Ineffective Erythropoiesis , 2010, Advances in hematology.

[6]  D. Gale,et al.  Erythropoietin administration in humans causes a marked and prolonged reduction in circulating hepcidin , 2010, Haematologica.

[7]  Jeffery L. Miller,et al.  Growth differentiation factor 15 in erythroid health and disease , 2010, Current opinion in hematology.

[8]  Y. T. Lee,et al.  Identification of TWSG1 as a second novel erythroid regulator of hepcidin expression in murine and human cells. , 2009, Blood.

[9]  L. Miranda,et al.  Development of a method for the sensitive and quantitative determination of hepcidin in human serum using LC-MS/MS. , 2009, Journal of pharmacological and toxicological methods.

[10]  A. Zanella,et al.  Regulation of iron metabolism through GDF15 and hepcidin in pyruvate kinase deficiency , 2009, British Journal of Haematology.

[11]  A. Look,et al.  Comprar Nathan and Oski's Hematology of Infancy and Childhood, 7th Edition | David E. Fisher | 9781416034308 | Saunders , 2009 .

[12]  M. Baiget,et al.  Does the SLC40A1 gene modify HFE-related haemochromatosis phenotypes? , 2009, Annals of Hematology.

[13]  S. Goh,et al.  High levels of GDF15 in thalassemia suppress expression of the iron regulatory protein hepcidin , 2007, Nature Medicine.

[14]  A. Zanella,et al.  Pyruvate kinase deficiency: the genotype-phenotype association. , 2007, Blood reviews.

[15]  T. Ganz,et al.  Liver iron concentrations and urinary hepcidin in beta-thalassemia. , 2007, Haematologica.

[16]  P. Horák,et al.  Endogenous Erythropoietin Levels and Anemia in Long-Term Renal Transplant Recipients , 2007, Kidney and Blood Pressure Research.

[17]  E. Neufeld,et al.  Urinary hepcidin in congenital chronic anemias , 2007, Pediatric blood & cancer.

[18]  T. Ganz,et al.  Suppression of hepcidin during anemia requires erythropoietic activity. , 2006, Blood.

[19]  G. Semenza,et al.  Hypoxia-inducible Factor-1 Deficiency Results in Dysregulated Erythropoiesis Signaling and Iron Homeostasis in Mouse Development* , 2006, Journal of Biological Chemistry.

[20]  E. Nečas,et al.  Hepcidin mRNA levels in mouse liver respond to inhibition of erythropoiesis. , 2006, Physiological research.

[21]  Paola Bianchi,et al.  Red cell pyruvate kinase deficiency: molecular and clinical aspects , 2005, British journal of haematology.

[22]  T. Ganz Hepcidin in iron metabolism , 2004, Current opinion in hematology.

[23]  Laurent R. Chiarelli,et al.  Structure and Function of Human Erythrocyte Pyruvate Kinase , 2002, The Journal of Biological Chemistry.

[24]  Tim G St Pierre,et al.  Ferritin crystal cataracts in hereditary hyperferritinemia cataract syndrome. , 2002, Investigative ophthalmology & visual science.

[25]  A. Zanella,et al.  Iron status and HFE genotype in erythrocyte pyruvate kinase deficiency: study of Italian cases. , 2001, Blood cells, molecules & diseases.

[26]  E. Costa,et al.  Hydrops fetalis associated with erythrocyte pyruvate kinase deficiency , 2000, European Journal of Pediatrics.

[27]  F. Costa,et al.  β‐thalassemia trait might increase the severity of hemochromatosis in subjects with the C282Y mutation in the HFE gene , 2000, American journal of hematology.

[28]  A. Zanella,et al.  Molecular characterization of PK-LR gene in pyruvate kinase-deficient Italian patients. , 1997, Blood.

[29]  B. Thiele,et al.  Molecular analysis of 29 pyruvate kinase-deficient patients from central Europe with hereditary hemolytic anemia. , 1997, Blood.

[30]  T. Lappin,et al.  Study of the molecular defects in pyruvate kinase deficient patients affected by nonspherocytic hemolytic anemia. , 1995, Blood cells, molecules & diseases.

[31]  A. Zanella,et al.  Iron status in red cell pyruvate kinase deficiency: study of Italian cases , 1993, British journal of haematology.

[32]  J. Kaplan,et al.  International Committee for Standardization in Haematology: Recommended Methods for Red‐Cell Enzyme Analysis * , 1977, British journal of haematology.

[33]  W. Valentine,et al.  A specific erythrocyte glycolytic enzyme defect (pyruvate kinase) in three subjects with congenital non-spherocytic hemolytic anemia. , 1961, Transactions of the Association of American Physicians.